These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 127378)

  • 1. Lymphocyte ATP-ase activity in treated cases of Hodgkin's disease.
    Ellegaard J; Traunberg H; Esmann V
    Scand J Haematol; 1975 Sep; 15(2):88-95. PubMed ID: 127378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-ase activity of lymphocytes from patients with carcinomas of the urinary bladder.
    Ellegaard J; Traunberg H; Dorff B
    Scand J Urol Nephrol; 1975; 9(2):105-9. PubMed ID: 124945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lymphocyte ATP-ase activity in patients with cancer of the uterine cervix.
    Ellegaard J; Traunberg H; Esmann V
    Acta Obstet Gynecol Scand; 1975; 54(3):223-6. PubMed ID: 125998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Sagher D; Karrison T; Schwartz JL; Larson RA; Strauss B
    Cancer Res; 1989 Oct; 49(19):5339-44. PubMed ID: 2548719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-ase activity of purified human normal T- and B-lymphocytes.
    Kragballe K; Ellegaard J
    Scand J Haematol; 1978 Mar; 20(3):271-9. PubMed ID: 148099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenosine deaminase activity in Hodgkin's disease (author's transl)].
    Müller G; Krug K; Krüger W; Richter V; Rassoul F
    Klin Wochenschr; 1982 Mar; 60(6):317-8. PubMed ID: 7078027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased lymphocyte ATP-ase activity in patients with carcinomas of the oral cavity and larynx.
    Ellegaard J; Traunberg H; Dorff B; Esmann V
    Acta Otolaryngol; 1975; 80(5-6):459-64. PubMed ID: 128275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymphocyte response in Hodgkin's disease.
    Braeman J; Evans IH; Deeley TJ
    Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma lysozyme in Hodgkin's disease. An indicator of increased macrophage activity?
    Hansen NE; Karle H
    Scand J Haematol; 1979 Feb; 22(2):173-8. PubMed ID: 432552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyl-beta-glucosaminidase in lymphocytes of patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
    Lisiewicz J
    Med Interne; 1976; 14(4):285-9. PubMed ID: 996426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy].
    Nagel GA; Pietra CD; Hartmann D; Rosenthal M; Albrecht R; Obrist R; Obrecht P
    Schweiz Med Wochenschr; 1979 Jan; 109(2):45-51. PubMed ID: 311514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte activation in patients with Hodgkin's disease.
    Kávai M; Berényi E; Zsindely A; Szegedi G; Fésüs L
    Int J Cancer; 1984 Oct; 34(4):483-5. PubMed ID: 6149193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoli and AgNORs in Hodgkin's disease.
    Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
    Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.